{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:04Z","timestamp":1790289064749,"version":"4.1.0"},"reference-count":33,"publisher":"BMJ","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"accepted":{"date-parts":[[2011,3,24]]},"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In addition to N-terminal pro-brain natriuretic peptide (NT-proBNP), red cell distribution width (RDW), growth differentiation factor (GDF)-15, interleukin (IL)-6 and creatinine are all potential circulating prognostic biomarkers in pulmonary arterial hypertension (PAH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To establish the relative prognostic utility of these biomarkers in patients with idiopathic PAH (IPAH) and to identify independent prognostic markers in this disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Circulating RDW, GDF-15, IL-6, creatinine and NT-proBNP levels were determined in 139 patients with IPAH (mean follow-up 4.0\u00b12.4\u2005years) and 40 age- and sex-matched healthy volunteers. Coincident clinical data and baseline haemodynamic measurements were also analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All the biomarkers except creatinine correlated with a 6\u2005min walk distance (6MWD; p&lt;0.05), and all but NT-proBNP correlated with WHO functional class (p&lt;0.01). GDF-15, creatinine and NT-proBNP correlated with mean right atrial pressures and cardiac index. RDW outperformed other biomarkers in receiver operating characteristic (ROC) analysis (area under the curve 0.820). Sensitive (&gt;80%) ROC-derived cut-off points of RDW (15.7%, p=0.001), GDF-15 (779\u2005pg\/ml, p&lt;0.001), IL-6 (2.5\u2005pg\/ml, p=0.019), creatinine (80.5\u2005\u03bcmol\/l, p=0.010) and NT-proBNP (491\u2005fmol\/ml, p&lt;0.001), all predicted survival in patients with IPAH over time. All the plasma biomarkers analysed predicted survival in Cox regression analysis, as did clinical and haemodynamic parameters. However, only RDW predicted survival independently of NT-proBNP and 6MWD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Circulating RDW, GDF-15, IL-6, creatinine and NT-proBNP levels are all related to disease severity and may be used to predict survival in patients with IPAH. RDW added significant prognostic value to measurements of NT-proBNP and exercise capacity and may prove valuable in a multiple biomarker approach to disease stratification.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/hrt.2011.224857","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T23:57:16Z","timestamp":1305071836000},"page":"1054-1060","source":"Crossref","is-referenced-by-count":152,"title":["Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension"],"prefix":"10.1136","volume":"97","author":[{"given":"Christopher J","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke S","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Simon R","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2011,5,10]]},"reference":[{"key":"2025092013423877000_97.13.1054.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.011"},{"key":"2025092013423877000_97.13.1054.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.05.016"},{"key":"2025092013423877000_97.13.1054.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200802-235OC"},{"key":"2025092013423877000_97.13.1054.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.933762"},{"key":"2025092013423877000_97.13.1054.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.719500"},{"key":"2025092013423877000_97.13.1054.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.067"},{"key":"2025092013423877000_97.13.1054.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.727545"},{"key":"2025092013423877000_97.13.1054.8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/gerona\/glp163","article-title":"Red cell distribution width and mortality in older adults: a meta-analysis","volume":"65","author":"Patel","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025092013423877000_97.13.1054.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.21.11514"},{"key":"2025092013423877000_97.13.1054.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.650846"},{"key":"2025092013423877000_97.13.1054.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.04.091"},{"key":"2025092013423877000_97.13.1054.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200712-1786OC"},{"key":"2025092013423877000_97.13.1054.13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205610"},{"key":"2025092013423877000_97.13.1054.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170431"},{"key":"2025092013423877000_97.13.1054.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.006"},{"key":"2025092013423877000_97.13.1054.16","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-6"},{"key":"2025092013423877000_97.13.1054.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.182014"},{"key":"2025092013423877000_97.13.1054.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1758"},{"key":"2025092013423877000_97.13.1054.19","doi-asserted-by":"publisher","DOI":"10.1080\/00365510802213550"},{"key":"2025092013423877000_97.13.1054.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00512.x"},{"key":"2025092013423877000_97.13.1054.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.898122"},{"key":"2025092013423877000_97.13.1054.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.911818"},{"key":"2025092013423877000_97.13.1054.23","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000041661.63285.AE"},{"key":"2025092013423877000_97.13.1054.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq226"},{"key":"2025092013423877000_97.13.1054.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1404"},{"key":"2025092013423877000_97.13.1054.26","doi-asserted-by":"crossref","unstructured":"Rhodes CJ Wharton J Howard L . Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur Respir J 2011. doi:10.1183\/09031936.00037711.","DOI":"10.1183\/09031936.00037711"},{"key":"2025092013423877000_97.13.1054.27","doi-asserted-by":"crossref","unstructured":"Ruiter G Lankhorst S Boonstra A . Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J. Published Online First: 30 September 2010. doi:10.1183\/09031936.00100510.","DOI":"10.1183\/09031936.00100510"},{"key":"2025092013423877000_97.13.1054.28","doi-asserted-by":"crossref","unstructured":"Soon E Treacy CM Toshner MR . Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension. Thorax 2011. doi: 10.1136\/thx.2010.147272.","DOI":"10.1136\/thx.2010.147272"},{"key":"2025092013423877000_97.13.1054.29","doi-asserted-by":"crossref","unstructured":"Rhodes CJ Howard LS Busbridge M . Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension: Clinical Prevalence, Outcomes and Mechanistic Insights. J Am Coll Cardiol 2011. In Press.","DOI":"10.1016\/j.jacc.2011.02.057"},{"key":"2025092013423877000_97.13.1054.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.07.024"},{"key":"2025092013423877000_97.13.1054.31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"2025092013423877000_97.13.1054.32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.8.865"},{"key":"2025092013423877000_97.13.1054.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.963983"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.2011.224857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:42:46Z","timestamp":1758400966000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.2011.224857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,10]]},"references-count":33,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2011,6,4]]},"published-print":{"date-parts":[[2011,7,1]]}},"alternative-id":["10.1136\/hrt.2011.224857"],"URL":"https:\/\/doi.org\/10.1136\/hrt.2011.224857","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,10]]}}}